IP Verse

Pharmaceutical Formulations Of A Hif Hydroxylase Inhibitor - EP3003284

PATENT ANALYSIS

Patent Details

Grant Date
Feb 12, 2020
Company
FIBROGEN, INC.
Oppositions

SANDOZ AG

TEVA PHARMACEUTICAL INDUSTRIES LTD.

More patents of Fibrogen, Inc.

EP2298301

EP3470397

EP3003284

Want to monitor this patent?

Feel free to send us a message here and we will get back to you